BioSpace News Archive

Press Releases

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 10, 2026

April 13, 2026
·
1 min read
Press Releases

Pelthos Therapeutics Announces CFO Transition

April 13, 2026
·
3 min read
Press Releases

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

April 13, 2026
·
27 min read
Press Releases

Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria

April 13, 2026
·
19 min read
Press Releases

Data Published in Nature Communications Highlights Unique Mechanism of Action of Alpibectir in Combination with Ethionamide (AlpE)

April 13, 2026
·
12 min read
Press Releases

SynOx Therapeutics Announces Positive Topline Results from the Phase 3 TANGENT Study, Supporting Emactuzumab as a Differentiated, Next-generation Treatment for Patients with Tenosynovial Giant Cell Tumor (TGCT)

April 13, 2026
·
7 min read
Press Releases

Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis

April 13, 2026
·
6 min read
Press Releases

Genflow Biosciences PLC Announces International Patent Publication

April 13, 2026
·
6 min read
Press Releases

Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain

April 13, 2026
·
2 min read
Press Releases

Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes

April 13, 2026
·
8 min read